Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel tumor vaccine claimed by Boehringer Ingelheim

Nov. 8, 1996

Hormonal agents from Yamanouchi

Nov. 8, 1996

Ilex compound for malignant brain tumors licensed to Janssen

Nov. 8, 1996

New taxane series disclosed by Indena

Nov. 8, 1996

Univ. of Tokyo researchers identify new antitumor antibiotics

Nov. 8, 1996

Novel piericidin antitumor antibiotics reported by Japanese and Chinese researchers

Nov. 8, 1996

Meiji Seika discloses antitumor antibiotics

Nov. 8, 1996

IND filing for SPI-77

Nov. 8, 1996

Debiopharm describes novel platinum complexes

Nov. 8, 1996

Hybridon's 1729 for multi-drug-resistant cancers

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.